KITE declines as holders exit and shorts rise, with weakening fundamentals and liquidity pointing to further downside risk.
Investors who were shorting biotech firm Kite Pharma woke up to some bad news Monday morning. Pharmaceutical company Gilead Sciences announced Monday that it’s buying the drug researcher for $11.9 ...
Disney Animation Studios is set to debut its second VR short film, A Kite’s Tale, late this month at the SIGGRAPH conference in Los Angeles. Disney says that A Kite’s Tale “combines classic hand-drawn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results